子午流注开穴法预防生长激素激发试验不良反应的临床观察

文章信息/Info

• Title:子午流注开穴法预防生长激素激发试验不良反应的临床观察

• 卷期:2024年22卷14期

• 作者:曹美珠

• 广州中医药大学顺德医院儿科(广东 佛山,528300)

• Author(s):Meizhu Cao

• ShunDe Hospital GuangZhou University of Chinese Meeicine(Guangdong Foshan 528300）

• 关键词子午流注；矮小症；生长激素激发试验；不良反应；疗效

• Keywords: meridian injection opening method;short stature;growth hormone provocation test;adverse reactions;clinical observation.

• 摘要:目的 观察子午流注开穴法预防生长激素激发试验不良反应的临床疗效。方法 选取2021年11月至2022年10月于我院进行生长激素激发试验的矮小儿童80例．随机分为对照组40例、观察组40例，对照组给予常规护理及治疗，观察组在对照组的基础上加予子午流注开穴法贴敷神阙穴，比较两组患儿出现不良反应的情况。结果 观察组不良反应发生率为7.5％，对照组不良反应发生率为27.5％，两者比较P<0．05，差异有统计学意义；其中观察组不良反应出现时间晚于对照组，不良反应持续时间少于对照组，两者比较P<0．05，差异有统计学意义。结论 子午流注开穴法贴敷神阙穴可降低生长激素激发试验不良反应的发生率，减少患儿痛苦，提高家属治疗满意度。保证激发试验顺利进行，值得临床推广。                                                                                                                                                                                

• Abstractthe clinical efficacy of meridian injection acupuncture to prevent adverse reactions of growth hormone provocation test.Methods 80 children with short stature were selected from November 2021 to October 2022 who underwent a growth hormone stimulation test in our hospital. They were randomly divided into two groups of 40 people each, the control group was given routine treatment and nursing, and the observation group was given the meridian injection opening method on the basis of the control group ,to compare the adverse reactions of the two groups.Results The incidence of adverse reactions in the observation group was 7.5%, while the control group was 27.5%, and the comparison between the two was P<0.05, and the difference was statistically significant; Among them, the occurrence time of adverse reactions in the observation group was later than that of the control group, and the duration of adverse reactions was less than that of the control group, and the comparison between the two was P<0.05, and the difference was statistically significant.Conclusion Meridian injection  opening method can reduce the incidence of adverse reactions to the growth hormone provocation test, reduce the pain of the child, and improve the satisfaction of family treatment. To ensure the smooth progress of the stimulation test, it is worth clinical promotion.

  矮小症[1]是指个体身高低于同年龄、同性别、同种族正常人群平均身高的2个标准差(-2SD)。相关研究表明，矮小患儿除了美观受损，在成长过程中还可能出现不同程度的生理、心理功能障碍，甚至直接影响成年后的生活质量[2-4]。矮小的病因很多，一般分为病理性矮小和正常变异性矮小[5], 病理性矮小通常包括生长激素缺乏症(GHD)、特发性矮小(ISS)、多垂体激素缺乏症(MPHD)、小于胎龄儿(SGA) 等。正常变异性矮小包括家族性矮小(FSS) 和体质性生长延迟(CDG)[6]。其中病理性矮小以GHD最为多见[6-8]。